tiprankstipranks
Core Laboratories N.V. (CLB)
NYSE:CLB
US Market
Want to see CLB full AI Analyst Report?

Core Laboratories (CLB) Earnings Dates, Call Summary & Reports

224 Followers

Earnings Data

Report Date
Jul 29, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
0.11
Last Year’s EPS
0.19
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:Apr 29, 2026|
% Change Since:
|
Earnings Call Sentiment|Negative
The call mixed clear operational and technological strengths (notable product wins, digital data progress, continued shareholder returns and a constructive multi‑year market outlook) with acute near-term headwinds. Q1 showed meaningful sequential revenue declines, sharp margin compression and steep earnings deterioration driven by the Middle East conflict, Russia/Ukraine disruptions, severe weather and higher costs—offset only partially by product/diagnostic demand in select regions and ongoing capital returns. Management expects modest sequential improvement in Q2 but the near-term outlook is still clouded by geopolitical and operational uncertainty.
Company Guidance
Core Lab guided Q2 2026 revenue of $123.0M–$131.0M, with segment guidance of Reservoir Description revenue $77.5M–$82.5M (operating income $3.5M–$5.4M) and Production Enhancement revenue $45.5M–$48.5M (operating income $2.8M–$4.7M), implying consolidated operating income of $6.4M–$10.2M (roughly a 7% operating margin) and EPS of $0.06–$0.12; the guidance excludes FX gains/losses and assumes a 25% effective tax rate. Management reiterated FY-2026 G&A ex-items of approximately $42M–$45M, capital expenditures (excluding insurance-covered U.K. rebuild) of $15M–$18M (historically ~2–4% of revenue), expects manufacturing absorption to align with projected product sales, and said it will continue to deploy free cash to the dividend and opportunistic share repurchases (Q1 free cash flow was $0.5M; cash $22.8M; net debt $94.2M; leverage ~1.2x).
Revenue and Seasonal Context
Q1 revenue was $121.8M, down 12% sequentially and down 1% year-over-year; management notes typical seasonal Q4→Q1 decline but emphasizes underlying demand pockets (e.g., Gulf of Mexico diagnostics) that partially offset softer regions.
Technology Wins and Customer Deployments
Successful deployments of proprietary technologies: GTX solution reduced water cut from 99% to 40% leading to an immediate 10-well campaign; FLOWPROFILER diagnostic in the Permian demonstrated stage-level oil contributions and is planned for 5 additional wells—demonstrating product-market traction.
Digital Data Strategy Progress
Delivered key reservoir datasets via Core’s proprietary rapid platform to standardize and digitize lab/reservoir data—improving turnaround, integration into client workflows and providing foundation for AI initiatives.
Shareholder Returns and Capital Allocation
Continued returning capital: repurchased >51,000 shares for ~$900,000 (sixth consecutive quarter of buybacks) while maintaining the quarterly dividend and indicating opportunistic future repurchases using free cash flow.
Forward Guidance and Modest Sequential Improvement Expected
Q2 guidance projects company revenue of $123M–$131M, operating income of $6.4M–$10.2M (~7% operating margin) and EPS of $0.06–$0.12, signaling expected modest sequential operational improvement.
Balance Sheet / Liquidity Maintenance
Net debt of $94.2M (long-term debt $117M less cash $22.8M) with leverage ~1.2x; free cash flow generation (Q1 FCF ~$0.5M) and FY26 CapEx guidance of $15M–$18M (ex-U.K. rebuild) reflect continued capital discipline and liquidity management.
Positive Long-Term Market Thesis
Management cites supportive industry fundamentals—IEA/EIA/OPEC forecast 2026 crude demand growth of ~0.6–1.4M bpd and accelerating field decline rates—supporting multiyear demand for Core’s reservoir and production enhancement technologies.

Core Laboratories (CLB) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CLB Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 29, 2026
2026 (Q2)
0.11 / -
0.19
Apr 29, 2026
2026 (Q1)
0.10 / 0.06
0.14-57.14% (-0.08)
Feb 04, 2026
2025 (Q4)
0.19 / 0.21
0.22-4.55% (-0.01)
Oct 22, 2025
2025 (Q3)
0.19 / 0.22
0.25-12.00% (-0.03)
Jul 23, 2025
2025 (Q2)
0.19 / 0.19
0.22-13.64% (-0.03)
Apr 23, 2025
2025 (Q1)
0.14 / 0.14
0.19-26.32% (-0.05)
Jan 29, 2025
2024 (Q4)
0.22 / 0.22
0.1915.79% (+0.03)
Oct 23, 2024
2024 (Q3)
0.24 / 0.25
0.2213.64% (+0.03)
Jul 24, 2024
2024 (Q2)
0.20 / 0.22
0.214.76% (+0.01)
Apr 24, 2024
2024 (Q1)
0.16 / 0.19
0.190.00% (0.00)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CLB Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 29, 2026
$17.30$14.65-15.32%
Feb 04, 2026
$19.60$18.77-4.23%
Oct 22, 2025
$12.75$16.43+28.82%
Jul 23, 2025
$12.59$13.33+5.86%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Core Laboratories N.V. (CLB) report earnings?
Core Laboratories N.V. (CLB) is schdueled to report earning on Jul 29, 2026, After Close (Confirmed).
    What is Core Laboratories N.V. (CLB) earnings time?
    Core Laboratories N.V. (CLB) earnings time is at Jul 29, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CLB EPS forecast?
          CLB EPS forecast for the fiscal quarter 2026 (Q2) is 0.11.